Infectious diseases I Bacteria I Viruses I Lipidomics I Sphingolipids I Nanobodies I Alumnus: @UtrechtUni @whiteheadinst/MIT @ragoninstitute of MGH, MIT&Harvard
Proximity labeling enthusiasts: check out this innovative study from my @CornellChem colleague Ciaran Seath on a genetically encoded small tag for intracellular PL. So cool to see a new use for Roger Tsien’s FlAsH — transformative ideas have long tails indeed.
Exciting times! 🎉
Thanks to an $8M NIH award, @OHSUNews is building a next-gen high-containment lab that will expand the science we need to take on future infectious disease threats. Grateful to everyone who made this possible!
https://t.co/bOzikuwBGL
What can we learn from all cytokines in the human genome? For most, we have limited info on what they do and when to target them
Meet TAPAS & EPICURE: tools to synthesize all human cytokines➡️scRNA data of primary human immune responses➡️🖥️methods to use them in your work (1/n)
Congratulations to everyone involved, especially Scotland Farley and Gaelen Guzman, and a huge thank-you to our longtime collaborator, @SchultzLabOHSU 🎉
@OHSUNews
To understand what a lipid does, we need to know its partners.
Which proteins bind lipids and how can we capture those interactions?
Our new Nature Protocols paper provides a practical, step-by-step guide to identifying lipid-binding proteins. 🧵
Together, the protocol and repository can make lipid-interactome studies more accessible and accelerate discovery across lipid biology, cell biology, and disease research.
Excited to share our latest paper in @J_Immunol. We report an MR1-specific nanobody that blocks MR1-mediated T cell activation.
Congrats to Tim Bates, Corinna from David Lewinsohn’s lab, and thanks to John Burke for HDX-MS support!
@OHSUNews
https://t.co/4CkdMnLqOT
NIH Common Fund announces 4️⃣ new funding opportunities for NIH Director’s High-Risk, High-Reward awards supporting exceptionally creative researchers with bold, innovative, high-impact ideas.
👉 Find the opportunity that fits your research: https://t.co/M1PieNJ4lc
The #Ebola situation in the #DRC is deeply worrisome. So far, 82 cases have been confirmed, with seven confirmed deaths. But we know the epidemic in the DRC is much larger. There are now almost 750 suspected cases and 177 suspected deaths.
The situation in #Uganda is currently stable, with two confirmed cases, and one death reported. There have been no new cases or deaths reported.
An American national who was working in DRC has also been confirmed positive, and transferred to Germany for care. We are aware of the reports today about another American national who is a high-risk contact who has been transferred to the Czech Republic.
These numbers are changing as surveillance efforts and laboratory testing is improving, but violence and insecurity are impeding the response.
Additional @WHO personnel have deployed to Ituri, the epicentre of the DRC outbreak, to support affected communities.
I am in regular contact with the government officials of the affected countries to coordinate response actions.
I have just convened a Member States briefing to update them on the ongoing response.
We’re hiring!
Our department at @OHSUNews is recruiting for a tenure-track faculty position. We seek outstanding candidates working broadly in molecular microbiology, immunology, and host–pathogen interactions.
Please share widely!
https://t.co/4EEaq6aGxs
PacTB is back in Portland on April 8–9, 2026!
West Coast TB folks (Bay Area, WA, Vancouver), especially grad students & postdocs, please join us! Great chance to present + network.
Abstract deadline: TODAY
Registration deadline: Apr 1
https://t.co/LMylzrlUEE
Glad to see this news story highlighting our recent lipid interactome database, a resource we hope will help the broader scientific community.
@OHSUNews@SchultzLabOHSU
https://t.co/VQ7OshAR7y